Europe PACS and RIS Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (PACS and RIS), Component (Hardware, Software, and Services), Deployment (Web-Based, On-Premise and Cloud-Based), End User (Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others)
The PACS and RIS market in Europe is expected to grow from US$ 779.0 million in 2019 to US$ 1,439.9 million by 2027; it is estimated to grow at a CAGR of 7.9% from 2020 to 2027.
The national rate for CT scans were 126 per 1,000 individuals around 2014 and 2015. Rates ranged from 209 (New Brunswick) and 170 (Newfoundland and Labrador) to 88 (Alberta) and 93 (Prince Edward Island). In addition, according to the National Health Services (NHS) UK, there were 4.1 million imaging tests conducted in England in the 12 months from February 2017 to January 2017. Of these, 3.49 million imaging tests were reported to have taken place in January 2017. Moreover, as per the World Health Organization (WHO), with improved health care policy and the guided protocol of medical imaging for COVID-19 diagnosis, there has been a rise in the number of imaging-based procedures. Thus, the growing number of diagnostic imaging procedures performed across the region resulting in the increasing requirement of consumables for tests are likely expected to drive the growth of the Europe PACS and RIS market over the coming years.
The rapid spread of the COVID-19 virus and the special care that critical patients need put a major pressure on the European healthcare system. Government of various European countries started employing plans to prepare for the crisis situation after the boom of infections hit Italy in April 2020. During the action plan, the private and public healthcare institutions raised demand for radiological imaging devices of high quality to provide accurate diagnostics to the sufferers. The hospital capacities were increased in various countries for immediate treatment of the patients. The NHS also closely monitoring supplies of various medical devices in various countries of the region and managed distribution networks to make the primary equipment available to hospitals and public healthcare centers. Thus, the efforts undertaken by government created a surge in demand for PACS and RISs during the pandemic in the European region.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the PACS and RIS market. The Europe PACS and RIS market is expected to grow at a good CAGR during the forecast period.
Europe PACS and RIS Market Revenue and Forecast to 2027(US$ Million)
Get more information on this report :
Europe PACS and RIS Market Segmentation
By Product
- Picture Archiving And Communication System (PACS)
- Radiology Information System (RIS)
By Component
- Hardware
- Software
- Services
By Deployment
- Web-Based
- On-Premise
- Cloud-Based
By End User
- Hospitals
- Diagnostic Centers
- Others
By Country
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Companies Mentioned
- Agfa-Gevaert Group
- INFINITT Healthcare Co., Ltd.
- McKesson Corporation
- Cerner Corporation
- General Electric Company
- Koninklijke Philips N.V.
- FUJIFILM Holdings Corporation
- Siemens AG
- IBM
- Novarad
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 PACS and RIS Market – By Product
1.3.2 PACS and RIS Market – By Component
1.3.3 PACS and RIS Market – By Deployment
1.3.4 PACS and RIS Market – By End User
1.3.5 Europe PACS and RIS Market – By Country
2. Europe PACS and RIS Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe PACS and RIS Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 PACS and RIS Market- Europe PEST Analysis
4.3 Expert Opinion
5. Europe PACS and RIS Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Developments in Diagnostic Imaging Modalities Coupled with Rising Number of Diagnostic Tests Procedures
5.1.2 Affordable Price of New Generation PACS Software
5.2 Market Restraints
5.2.1 Availability of Better Substitutes
5.2.2 Concerns Regarding Data Privacy
5.3 Market Opportunities
5.3.1 Increasing Demand for Orthopaedic PACS
5.4 Market Trends
5.4.1 Technology Advancement and New Product Launches
5.5 Impact Analysis
6. PACS and RIS Market – Europe Analysis
6.1 Europe PACS and RIS Market Revenue Forecasts and Analysis
7. Europe PACS and RIS Market Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 Europe PACS and RIS Market, By Product, 2019 & 2027 (% Share)
7.3 Picture Archive and Communication System (PACS) Market
7.3.1 Overview
7.3.2 Europe Picture Archive and Communication System (PACS) Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Radiology Information System (RIS) Market
7.4.1 Overview
7.4.2 Europe Radiology Information System (RIS) Market Revenue and Forecasts to 2027 (US$ Mn)
8. Europe PACS and RIS Market Analysis and Forecasts To 2027 – By Component
8.1 Overview
8.2 Europe PACS and RIS Market, By Component, 2019 & 2027 (% Share)
8.3 Software Market
8.3.1 Overview
8.3.2 Europe Software Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Hardware Market
8.4.1 Overview
8.4.2 Europe Hardware Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Services Market
8.5.1 Overview
8.5.2 Europe Services Market Revenue and Forecasts to 2027 (US$ Mn)
9. Europe PACS and RIS Market Analysis and Forecasts To 2027 – By Deployment
9.1 Overview
9.2 Europe PACS and RIS Market, By Deployment 2019 & 2027 (% Share)
9.3 Web-Based Market
9.3.1 Overview
9.3.2 Europe Web-Based Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 On-Premise Market
9.4.1 Overview
9.4.2 Europe On-Premise Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Cloud-Based Market
9.5.1 Overview
9.5.2 Europe Cloud-Based Market Revenue and Forecasts to 2027 (US$ Mn)
10. Europe PACS and RIS Market Analysis and Forecasts to 2027– By End User
10.1 Overview
10.2 Europe PACS and RIS Market, By End User, 2019 & 2027 (% Share)
10.3 Hospitals Market
10.3.1 Overview
10.3.2 Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Diagnostic Centers Market
10.4.1 Overview
10.4.2 Europe Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Others Market
10.5.1 Overview
10.5.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
11. PACS and RIS Market Revenue and Forecasts to 2027 – Geographical Analysis
11.1 Europe PACS and RIS Market Revenue And Forecasts To 2027
11.1.1 Europe PACS and RIS Market Revenue And Forecasts to 2027, By Country (%)
11.1.2 UK PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.2.1 UK PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.2.2 UK PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.2.3 UK PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.1.2.4 UK PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.1.2.5 UK PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.3 Germany PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.3.1 Germany PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.3.2 Germany PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.3.3 Germany PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.1.3.4 Germany PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.1.3.5 Germany PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.4 France PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.4.1 France PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.4.2 France PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.4.3 France PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.1.4.4 France PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.1.4.5 France PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.5 Italy PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.5.1 Italy PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.5.2 Italy PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.5.3 Italy PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.1.5.4 Italy PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.1.5.5 Italy PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.6 Spain PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.6.1 Spain PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.6.2 Spain PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.6.3 Spain PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.1.6.4 Spain PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.1.6.5 Spain PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
11.1.7 Rest of Europe: Medical Device Adhesive Market – Revenue and Forecast to 2027 (USD Million)
11.1.7.1 Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.7.2 Rest of Europe PACS and RIS Market Revenue And Forecasts to 2027, By Product (US$ Mn)
11.1.7.3 Rest of Europe PACS and RIS Market Revenue And Forecasts to 2027, By Component (US$ Mn)
11.1.7.4 Rest of Europe PACS and RIS Market Revenue And Forecasts to 2027, By Deployment (US$ Mn)
11.1.7.5 Rest of Europe PACS and RIS Market Revenue And Forecasts to 2027, By End User (US$ Mn)
12. Impact Of COVID-19 Pandemic on Europe PACS and RIS Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Inorganic Growth Strategies
13.2.1 Overview
13.3 Inorganic Growth Strategies in the PACS and RIS Market, 2017-2020 (%)
13.3.1 Collaborations
13.3.1.1 Recent Collaborations By Players In The PACS and RIS Market
13.3.2 Agreements, Partnerships and Joint Ventures
13.3.2.1 Recent Agreements, Partnerships And Joint Ventures By Players In The PACS and RIS Market
13.3.3 Acquisitions
13.3.3.1 Recent Acquisitions By Players In The PACS and RIS Market
13.4 Organic Growth Strategies
13.4.1 Overview
13.5 Organic Growth Strategies in the PACS and RIS Market, 2017-2020 (%)
13.5.1 Product Launches
13.5.1.1 Recent Product Launches By Players In The PACS and RIS Market
13.5.2 Product Approval & Other Organic Growth Strategies
13.5.2.1 Recent Product Approval & Other Organic Growth Strategies By Players In The PACS and RIS Market
14. COMPANY PROFILES
14.1 Agfa-Gevaert Group
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Financial Overview
14.1.4 Product Portfolio
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 INFINITT Healthcare Co., Ltd.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Financial Overview
14.2.4 Product Portfolio
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 McKesson Corporation
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Financial Overview
14.3.4 Product Portfolio
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Cerner Corporation
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Financial Overview
14.4.4 Product Portfolio
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 General Electric Company
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Financial Overview
14.5.4 Product Portfolio
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Koninklijke Philips N.V.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Financial Overview
14.6.4 Product Portfolio
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 FUJIFILM Holdings Corporation
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Financial Overview
14.7.4 Product Portfolio
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Siemens AG
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Financial Overview
14.8.4 Product Portfolio
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 IBM
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 Product Portfolio
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Novarad
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Financial Overview
14.10.4 Product Portfolio
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. UK PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 2. UK PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 3. UK PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 4. UK PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 5. Germany PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 6. Germany PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 7. Germany PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 8. Germany PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 9. France PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 10. France PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 11. France PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 12. France PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 13. Italy PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 14. Italy PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 15. Italy PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 16. Italy PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 17. Spain PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 18. Spain PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 19. Spain PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 20. Spain PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 21. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027, By Product (US$ Mn)
Table 22. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027, By Component (US$ Mn)
Table 23. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027, By Deployment (US$ Mn)
Table 24. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 25. Recent Collaborations by Players in The PACS and RIS Market
Table 26. Recent Agreements, Partnerships and Joint Ventures by Players in The PACS and RIS Market
Table 27. Recent Acquisitions by Players in The PACS and RIS Market
Table 28. Recent Product Launches in the PACS and RIS Market
Table 29. Recent Product Approval & Other Organic Growth Strategies in the PACS and RIS Market
Table 30. Glossary of Terms, PACS and RIS Market
LIST OF FIGURES
Figure 1. PACS and RIS Market Segmentation
Figure 2. Europe PACS and RIS Market Overview
Figure 3. Picture Archive and Communication System (PACS) Segment Held Largest Share of Product in PACS and RIS Market
Figure 4. Software Segment Held Largest Share of Component in PACS and RIS Market
Figure 5. UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. PACS and RIS Market - Europe PEST Analysis
Figure 7. PACS and RIS Market Impact Analysis of Driver and Restraints
Figure 8. Europe PACS and RIS Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Europe PACS and RIS Market, by Product, 2019 & 2027 (% Share)
Figure 10. Europe Picture Archive and Communication System (PACS) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Europe Radiology Information System (RIS) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Europe PACS and RIS Market, by Component, 2019 & 2027 ((% Share)
Figure 13. Europe Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Europe Hardware Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Europe Services Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Europe PACS and RIS Market, By Deployment, 2019 & 2027 (% Share)
Figure 17. Europe Web-Based Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Europe On-Premise Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Europe Cloud-Based Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Europe PACS and RIS Market, By End User, 2019 & 2027 (% Share)
Figure 21. Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Europe Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Europe PACS and RIS Market Revenue Overview, by Country, 2019 (US$ MN)
Figure 25. Europe PACS and RIS Market Revenue and Forecasts to 2027, By Country (%)
Figure 26. UK PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Germany PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. France PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Italy PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Spain PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. Rest of Europe PACS and RIS Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. Impact of COVID-19 Pandemic in European Country Markets
Figure 33. Growth Strategies Done by the Companies in the Market, (%)
Figure 34. Inorganic Developments in the PACS and RIS Market, 2017-2020 (%)
Figure 35. Organic Growth Strategies in the PACS and RIS Market, 2017-2020 (%)
The List of Companies - Europe PACS and RIS Market
- Agfa-Gevaert Group
- INFINITT Healthcare Co., Ltd.
- McKesson Corporation
- Cerner Corporation
- General Electric Company
- Koninklijke Philips N.V.
- FUJIFILM Holdings Corporation
- Siemens AG
- IBM
- Novarad
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe PACS and RIS market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe PACS and RIS market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the PACS and RIS market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution